CHI ADVISORS LLC other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

Registration status: Terminated

As of Date:

12/17/2023

Adviser Type:

- Large advisory firm


Number of Employees:

34

of those in investment advisory functions:

8

AUM:

1,156,715,814 -0.51%

of that, discretionary:

1,156,715,814 -0.51%

GAV:

0 -100.00%

Avg Account Size:

192,785,969 32.65%


SMA’s:

YES

Private Funds:

0 6

Contact Info

646 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
1B 997M 830M 664M 498M 332M 166M
2019 2020 2021 2022 2023

Recent News

CHI Advisors LLC Buys Prometheus Biosciences Inc, Prometheus Biosciences Inc, Oncorus Inc, ...
05/14/2021

Related Stocks: ORTX, CRVS, KZR, RXDX, RXDX, ONCR, AMWL, BLUE,

gurufocus.com

Orchard Therapeutics PLC ADR
03/30/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Orchard Therapeutics PLC ADR
03/29/2021

1 Day ORTX -4.08% DJIA -0.30% S&P Mid Cap 400 -1.85% Health Care/Life Sciences 1.99% Bobby Gaspar Chief Executive Officer & Executive Director Alliance for Regenerative Medicine, Orchard ...

Wall Street Journal

Cogent Biosciences Inc.
03/26/2021

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Barrons

Private Funds



Employees




Brochure Summary

Overview

CHI Advisors LLC (the “Adviser”) is a Delaware Limited Liability Company formed in 2002, a wholly owned subsidiary of Cowen Investment Management LLC ("CIM") and an indirect, wholly owned subsidiary of Cowen Inc., (“Cowen”). This brochure does not constitute an offer to sell or solicitation of an offer to buy any securities. In March 2023 the Advisor became an indirect, wholly owned subsidiary of The Toronto-Dominion Bank (“TD”) as a result of TD’s acquisition of Cowen. The Adviser provides discretionary investment management services to private limited partnerships and other pooled investment vehicles (each, a “Fund” and together, the “Funds”). The Adviser also provides discretionary investment management services to investment vehicles formed in order to allow employees, partners, executive advisors or members of a Fund's general partner, the Adviser or their respective affiliates to participate directly or indirectly in a Fund's investments. While not considered an advisory client, the Adviser also manages a securities portfolio beneficially owned by its parent company, Cowen, that invests in securities that are also held (or previously held) by the Funds. The Adviser may in the future provide discretionary investment management services to hedge funds and separate accounts. The Funds, the securities portfolio beneficially owned by Cowen, employee investment vehicles, and any hedge funds and separate accounts that may be managed by the Adviser are collectively referred to herein as “Clients”. The Adviser is responsible for managing the capital of its Clients in accordance with their respective investment objectives. Clients investing in the Adviser’s private markets strategy primarily invest in equity or convertible debt securities of private operating companies engaged primarily in businesses related to healthcare. Certain Clients investing in the private markets strategy also invest in initial public offerings (an "IPO") of equity securities of healthcare-related companies in which a Client has previously invested. The Adviser also offers a public markets strategy to Clients that focuses on investments in publicly traded healthcare companies in which the Adviser has previously invested in or performed due diligence on while those companies were privately held. The Adviser’s management of its Clients and their respective investments are qualified in their entirety by reference to each Client's agreement with
the Adviser as well as in formal offering documents (e.g., the Client’s offering memorandum, limited partnership agreement, or investment management agreement as the case may be, and any subscription documents). These documents are collectively referred to herein as the Clients’ “Offering Documents”. The Adviser currently acts as the agent for: (i) Cowen Healthcare Investments II GP LLC, a Delaware limited liability company that serves as the general partner to Cowen Healthcare Investments II, LP and CHI EF II LP; (ii) Cowen Healthcare Investments III GP LLC, a Delaware limited liability company that serves as the general partner to Cowen Healthcare Investments III, LP and CHI EF III, LP; and (iii) Cowen Healthcare Investments IV GP LLC, a Delaware limited liability company that serves as the general partner to Cowen Healthcare Investments IV, LP and CHI EF IV LP. Certain investment-related determinations, decisions, consents or other duties or actions described in a Client's limited partnership agreement as being the determinations, decisions, consents, duties or actions of such general partner will be performed by the Adviser in such capacity. The descriptions of the investment management services offered by the Adviser, the investment strategy it pursues, and the investments it makes on behalf of its Clients set forth in this brochure should not be understood to limit in any way the Adviser's investment activities. The Adviser may offer any advisory services, engage in any investment strategy and make any investment, including any not described in this brochure, that the Adviser considers appropriate, subject to a Client's investment objectives and guidelines. The investment strategies the Adviser pursues are speculative and entail substantial risks. Clients (and any respective investors therein) should be prepared to bear a substantial loss of capital. There can be no assurance that the investment objectives of any Client will be achieved. As of January 1, 2022, the Adviser managed approximately U.S. $1,153,230,000 of Client assets on a discretionary basis.1 This number is net of fees and expenses, includes unfunded capital commitments and is based on estimated and unaudited information and is therefore subject to change. The Adviser does not currently manage any non- discretionary Client assets or participate in wrap fee programs.